glp 1 gip dual agonist weight loss GLP-1 Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care Frontiers | GLP-1/GIP dual agonist

To make sure Jardiance is safe for you, talk to your doctor if you have a history of: Severe renal impairment Chronic kidney disease or liver disease Bladder infections or urinary tract infections Pancreatitis Alcoholism Genital infection Follow your doctor's instructions about using Jardiance if you're pregnant or planning to become pregnant

(What Is GLP-1?) GLP-1 (Glucagon-Like Peptide-1) is a natural gut hormone released by intestinal L-cells after eating

Cardiovascular Outcomes: The SELECT Trial Revolution Breakthrough Cardiovascular Evidence The Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) trial represents a paradigm shift in obesity treatment by demonstrating cardiovascular benefits independent of diabetes status

It randomised 156 participants with early disease to daily subcutaneous lixisenatide or placebo for 12 months, followed by a 2-month washout

Practical access strategies For patients in markets where both peptides are available, tirzepatide is the practical choice due to established availability, known dosing protocols, extensive clinical experience, and insurance coverage pathways